文献速递炎症性肠病

低剂量阿司匹林对妊娠期炎症性肠病患者疾病活动的影响

The Effect of Low-Dose Aspirin on Disease Activity in Pregnant Individuals With Inflammatory Bowel Disease.
PubMed 文献 · Am J Gastroenterol · 2025-01-07

该研究纳入2013年1月1日至2022年12月31年间在母胎医学中心随访的炎症性肠病(IBD)妊娠患者,评估低剂量阿司匹林(LDA)使用率及其对IBD疾病活动的影响。在320例妊娠(232例患者)中,90例(28%)在妊娠期使用阿司匹林。妊娠期或产后IBD发作率在用药组与未用药组间相似(20% vs 26%,P=0.36),LDA使用与疾病活动风险增加无关。

要点

  • 在母胎医学中心随访的IBD妊娠患者中,约三分之一被处方LDA。
  • 妊娠期或产后IBD发作率在LDA组与未用药组间无显著差异(20% vs 26%,P=0.36)。
  • LDA使用与IBD疾病活动风险增加无关。

核心结论

  • 妊娠期IBD患者使用阿司匹林与疾病活动风险增加无关。

研究设计与样本

  • 纳入2013年1月1日至2022年12月31日在母胎医学中心随访的IBD妊娠患者,共320例妊娠(232例患者)。
  • LDA使用情况从妊娠期用药清单中确认。
  • 主要结局为妊娠期或产后6个月内IBD发作,定义为IBD相关住院或手术、启动新治疗、粪便钙卫蛋白升高或新发活动性内镜病变。

主要发现

  • 320例妊娠中90例(28%)在妊娠期被处方阿司匹林。
  • 妊娠期或产后IBD发作率在处方阿司匹林组与未处方组间相似(20% vs 26%,P=0.36)。
  • 与未使用LDA者相比,使用阿司匹林者年龄更大(中位数35 vs 34岁)、早产率更高(21% vs 14%)、产次更多(2 vs 1)、剖宫产率更高(50% vs 27%),均P<0.01。
  • 两组妊娠期高血压疾病(HDP)发生率相似,但使用LDA组子痫前期发生率更高(10% vs 4.3%,P=0.10)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Low-dose aspirin (LDA) is recommended for pregnant individuals at elevated risk for hypertensive disorders of pregnancy (HDP). However, regular aspirin use may raise concerns of increased disease activity in patients with inflammatory bowel disease (IBD). We aimed to evaluate the prevalence of LDA use in pregnant IBD patients and the effect of LDA on IBD disease activity. METHODS: Included were individuals with IBD and pregnancy followed by maternal fetal medicine between January 1, 2013, and December 31, 2022. LDA use was ascertained from medication lists during pregnancy. Primary outcome was IBD flare during pregnancy or 6-month postpartum, defined as IBD-related hospitalization or surgery, new therapy initiation, elevated fecal calprotectin, or new active endoscopic disease. RESULTS: Among 320 pregnancies in women with IBD (232 patients), 90 (28%) were prescribed aspirin during pregnancy. The percentage of women with IBD flare during pregnancy or postpartum was similar among those who were and were not prescribed aspirin (20% vs 26%, P = 0.36). Individuals on aspirin were older (35 vs 34 median years), more likely to have preterm birth (21% vs 14%), higher parity (2 vs 1), and cesarean delivery (50% vs 27%) than individuals not on LDA (all P < 0.01). Both groups had similar rates of HDP, although individuals on LDA had higher rates of preeclampsia (10% vs 4.3%, P = 0.10). DISCUSSION: Approximately one-third of patients with IBD cared for in a maternal fetal medicine practice were prescribed LDA during pregnancy. The use of aspirin among pregnant patients with IBD was not associated with an increased risk of disease activity.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Memel Z, Yu A, Fenton C, et al. The Effect of Low-Dose Aspirin on Disease Activity in Pregnant Individuals With Inflammatory Bowel Disease. Am J Gastroenterol. 2025. PMID: 39773571. doi:10.14309/ajg.0000000000003304

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。